Cyclodynon (tranexamic acid) oral drops 50 ml.


Manufacturer: Germany



Bleeding or risk of bleeding with increased fibrinolysis, both generalized and local: menorrhagia, metrorrhagia, nasal, pulmonary, gastrointestinal bleeding, hematuria, bleeding during and after operations on the prostate, urinary tract organs, ENT organs (adenoidectomy, tonsillectomy, tooth extraction), on the organs of the thoracic and abdominal cavities, during and after gynecological operations, obstetric manipulations and other surgical procedures interventions, in cardiovascular surgery, bleeding during pregnancy, postpartum bleeding, ru e Department of the afterbirth, chorion detachment, malignant neoplasm of the pancreas and prostate, hemophilia, bleeding after prostatectomy, cervical conization for carcinoma, thrombocytopenic purpura, leukemia, liver disease, previous streptokinase therapy. Surgical procedures for systemic inflammatory reactions (sepsis, peritonitis, pancreonecrosis, severe and moderate gestosis, shock of various etiologies, and other critical conditions). Hemorrhagic complications in fibrinolytic therapy.